A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension
This study is currently recruiting participants.
Verified January 2013 by Allergan
Information provided by (Responsible Party):
First received: January 30, 2013
Last updated: January 31, 2013
Last verified: January 2013
This study will assess angle width in Chinese patients with Open-angle Glaucoma and/or Ocular Hypertension.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Allergan:
Primary Outcome Measures:
- Anterior Angle Width as Measured by Anterior Segment Optical Coherence Tomography [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Anterior Angle Width as Measured by Gonioscopic Lens with Shaffer Grading [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
- Anterior Angle Width as Measured by Gonioscopic Lens with Step Grading [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
|Study Start Date:||January 2013|
|Estimated Study Completion Date:||September 2013|
|Estimated Primary Completion Date:||September 2013 (Final data collection date for primary outcome measure)|
OAG and/or OHT patients
Open-Angle Glaucoma (OAG) and/or Ocular Hypertension (OHT) patients.
Other: No Treatment
No Treatment was given in this study.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01781962
|Contact: Allergan Inc.||email@example.com|
Sponsors and Collaborators
|Study Director:||Medical Director||Allergan|